Hypoxia as a Central Regulator of Plasma Membrane Phosphohydrolase Enzymes: Possible Roles in Extracellular Phosphate...

This article presents a conceptual perspective proposing that hypoxia acts as a unifying regulator of plasma membrane phosphohydrolases. We propose that oxygen sensing at the cell surface integrates adenosine and phosphate metabolism to sustain tumour adaptation. Within the oxygen- and nutrient-deprived tumour microenvironment, inorganic phosphate (Pi) and adenosine function as metabolic substrates and signalling mediators that promote cell proliferation, survival, and immune evasion. Stabilisation of hypoxia-inducible factor-1α (HIF-1α) enhances the expression and catalytic activity of specific phosphohydrolases, notably the ectonucleotidases CD39 (NTPDase1) and CD73 (ecto-5'-nucleotidase), which drive adenosine accumulation and immunosuppression. Conversely, the activity of transmembrane prostatic acid phosphatase (TM-PAP), responsible for hydrolysing phosphate esters such as p-nitrophenylphosphate (pNPP) and AMP, is inhibited under hypoxia through oxidative and kinase-dependent mechanisms. Collectively, these mechanisms characterise the plasma membrane as a dynamic metabolic interface, where oxygen sensing coordinates adenosine and phosphate turnover, thereby promoting tumour adaptation across hypoxic environments. We propose that hypoxia orchestrates a dual regulatory loop connecting adenosine accumulation and phosphate turnover at the tumour cell surface, providing a conceptual basis for future mechanistic studies.